other material
confidence high
sentiment negative
materiality 0.80
CERO Therapeutics issues ~84M new common shares and 8.4M warrants in December capital actions
CERO THERAPEUTICS HOLDINGS, INC.
- From Dec 6-26, ~2,600 Series A and 213 Series B preferred shares converted into ~68M common shares.
- Issued 8.4M warrants at $0.0561/share to institutional investors on Dec 23 as condition to warrant exercises.
- Equity line issued ~16M common shares for ~$700k cash proceeds Dec 6-30.
- Preferred warrants exercised: 962 warrants for $962k stated value, netting $769.6k cash.